LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 116

Search options

  1. Article ; Online: Re Letter to the editor re: Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhinoconjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin 2013 Jul 5.

    Compalati, Enrico / Canonica, Giorgio Walter

    Current medical research and opinion

    2014  Volume 30, Issue 2, Page(s) 207–209

    MeSH term(s) Conjunctivitis, Allergic/drug therapy ; Cyproheptadine/analogs & derivatives ; Histamine Antagonists/therapeutic use ; Humans ; Rhinitis, Allergic, Perennial/drug therapy ; Rhinitis, Allergic, Seasonal/drug therapy
    Chemical Substances Histamine Antagonists ; Cyproheptadine (2YHB6175DO)
    Language English
    Publishing date 2014-02
    Publishing country England
    Document type Comment ; Letter
    ZDB-ID 80296-7
    ISSN 1473-4877 ; 0300-7995
    ISSN (online) 1473-4877
    ISSN 0300-7995
    DOI 10.1185/03007995.2013.855191
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Importance of the Diaphragm in Neuromotor Function in the Patient with Chronic Obstructive Pulmonary Disease.

    Bordoni, Bruno / Escher, Allan / Compalati, Elena / Mapelli, Luca / Toccafondi, Anastasia

    International journal of chronic obstructive pulmonary disease

    2023  Volume 18, Page(s) 837–848

    Abstract: Chronic obstructive pulmonary disease (COPD) is a constant and chronic narrowing of the respiratory airways, with numerous associated symptoms, not always related to the pathological adaptation of the lungs. Statistical projections show that COPD could ... ...

    Abstract Chronic obstructive pulmonary disease (COPD) is a constant and chronic narrowing of the respiratory airways, with numerous associated symptoms, not always related to the pathological adaptation of the lungs. Statistical projections show that COPD could become the third leading cause of death globally by 2030, with a significant increase in deaths by 2060. Skeletal muscle dysfunction, including the diaphragm, is one of the causes linked to the increase in mortality and hospitalization. Little emphasis is given by the scientific literature to the importance of the diaphragm towards functional neuromotor pathological expressions. The article reviews the adaptation of the skeletal muscles, with greater attention to the adaptations of the diaphragm, thereby highlighting the non-physiological variations that the main respiratory muscle undergoes and the neuromotor impairment found in COPD. The text could be an important reflection from a clinical and rehabilitation point of view, to direct greater attention to the function and adaptation of the diaphragm muscle.
    MeSH term(s) Humans ; Diaphragm ; Pulmonary Disease, Chronic Obstructive/complications ; Respiratory Muscles ; Lung ; Muscle, Skeletal
    Language English
    Publishing date 2023-05-11
    Publishing country New Zealand
    Document type Review ; Journal Article
    ZDB-ID 2212419-6
    ISSN 1178-2005 ; 1176-9106
    ISSN (online) 1178-2005
    ISSN 1176-9106
    DOI 10.2147/COPD.S404190
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Update meta-analysis on the efficacy and safety issues of fexofenadine.

    Gómez, René Maximiliano / Moreno, Pablo / Compalati, Enrico / Canonica, Giorgio Walter / Ansotegui Zubeldia, Ignacio Javier

    The World Allergy Organization journal

    2023  Volume 16, Issue 7, Page(s) 100795

    Abstract: Background: Fexofenadine emerged as one of the most representative second generation histamine H1 antagonist drugs since the 1990s, with an outstanding efficacy and appreciable safety for the treatment of allergic patients. While allergic rhino- ... ...

    Abstract Background: Fexofenadine emerged as one of the most representative second generation histamine H1 antagonist drugs since the 1990s, with an outstanding efficacy and appreciable safety for the treatment of allergic patients. While allergic rhino-conjunctivitis represents the most frequent atopic disease globally, an update of fexofenadine efficacy and safety on this entity was proposed as a surrogate of allergic condition.
    Methods: Double blind, placebo controlled, randomized clinical trials investigating the efficacy and safety of fexofenadine for the treatment of Allergic Rhinitis were searched in 5 major global databases. Eligibility criteria and characteristics, risk of bias, and validity assessment, data extraction and heterogeneity evaluation are described. Primary outcome selected corresponded to 12-reflective and instantaneous total symptom scores (TSS), besides morning instantaneous TSS and the frequency of reported adverse events (AEs); analysis was planned on the intention-to-treat population.Standardized mean differences of scoring systems were analyzed, and Cochran's Q statistic test and the I
    Results: From the initial 83 identified records, 12 eligible studies were selected. In the evaluated patients, individuals receiving fexofenadine (1910) showed a significant reduction of TSS compared with those who received placebo (1777), change from baseline: standardized mean difference (SMD) -0.33; 95% CI-0.47 to -0.18, p < 0.0001. Morning instantaneous TSS also demonstrated lower symptoms (change from baseline: SMS -1.42; 95% CI -2.22 to -0.62, p = 0.0005). Heterogeneity was found across selected studies.Frequency of AEs was similar compared to placebo (OR = 1.04; 0.88-1.21), with no detection of heterogeneity across these 12 studies.
    Conclusions: According to this new evidence, fexofenadine maintains its beneficial profile on signs and symptoms of patients with allergic conditions, as well as its attributes as one of the major candidates for an ideal antihistamine medication (including special conditions such as pregnancy and pre-school age), providing support to its over-the-counter condition in several countries.
    Language English
    Publishing date 2023-07-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2581968-9
    ISSN 1939-4551
    ISSN 1939-4551
    DOI 10.1016/j.waojou.2023.100795
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Safety of subcutaneous and sublingual immunotherapy with allergoids in children: a real-life pharmacovigilance study.

    Frati, Franco / Beni, Noemi De / Marastoni, Laura / Compalati, Enrico / Ciprandi, Giorgio

    Immunotherapy

    2023  Volume 16, Issue 1, Page(s) 43–53

    Abstract: Aims: ...

    Abstract Aims:
    MeSH term(s) Child ; Humans ; Sublingual Immunotherapy/adverse effects ; Allergoids ; Pharmacovigilance ; Desensitization, Immunologic/adverse effects ; Desensitization, Immunologic/methods ; Injections, Subcutaneous ; Allergens/therapeutic use ; Rhinitis, Allergic
    Chemical Substances Allergoids ; Allergens
    Language English
    Publishing date 2023-11-29
    Publishing country England
    Document type Journal Article
    ZDB-ID 2495964-9
    ISSN 1750-7448 ; 1750-743X
    ISSN (online) 1750-7448
    ISSN 1750-743X
    DOI 10.2217/imt-2023-0126
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Caregivers of Neuromuscular Patients Living with Tracheostomy during COVID-19 Pandemic: Their Experience.

    Pierucci, Paola / Volpato, Eleonora / Grosso, Francesca / De Candia, Maria Luisa / Casparrini, Massimo / Compalati, Elena / Pagnini, Francesco / Banfi, Paolo / Carpagnano, Giovanna Elisiana

    Journal of clinical medicine

    2023  Volume 12, Issue 2

    Abstract: Background: During a pandemic, tracheostomy management in neuromuscular disease (NMD) patients can be complex. Methods: Using a multicentre, multiple case study approach, we sought perspectives through semi-structured interviews via hybrid quali- ... ...

    Abstract Background: During a pandemic, tracheostomy management in neuromuscular disease (NMD) patients can be complex. Methods: Using a multicentre, multiple case study approach, we sought perspectives through semi-structured interviews via hybrid quali-quantitative analysis. The qualitative analysis involved a semi-structured interview and the quantitative analysis the completion of a battery of questionnaires. Aim: To investigate the caregivers’ experiences, burden and beliefs regarding tracheostomy during the Italian COVID-19 pandemic. The following instruments were administered: Connor and Davidson Resilience Scale (CD-RISC-25); Acceptance and Action Questionnaire-II (AAQ-II); State-Trait Anxiety Inventory (STAI); Langer Mindfulness Scale (LMS); Zarit Burden Interview (ZBI). Results: Fifty-three caregivers (62.3% female, mean age 52.2 (SD = 18.2)) participated in the study. The more resilient the carers, the more they were psychologically flexible (r = 0.380, p = 0.014) and able to cope adaptively with the emergency (r = 0.378, p < 0.006). Similarly, perceived control was higher the more resilient they were (r = 0.897, p < 0.001). The main emotions emerging were isolation and loneliness (15; 34.88%). The perception of tracheostomy meant that it could be seen as a lifesaver or as a condemnation. Similarly, the relationship with health professionals moves from satisfaction to a feeling of abandonment over the course of the pandemic. Conclusions: These findings offer a unique opportunity to understand the point of view of caregivers of NMD patients living with tracheotomy during the COVID-19 pandemic, when going to the hospital may have been hampered.
    Language English
    Publishing date 2023-01-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12020555
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The pathogenesis of OSA-related hypertension: what are the determining factors?

    Battaglia, Elvia / Banfi, Paolo / Compalati, Elena / Nicolini, Antonello / Diaz DE Teran, Teresa / Gonzales, Monica / Solidoro, Paolo

    Minerva medica

    2023  Volume 115, Issue 1, Page(s) 68–82

    Abstract: Sleep-disordered breathing has a relatively high prevalence, which varies from 3-7% in males and from 2-5% in females in the adult population. Studies published in the literature have shown that sleep apnea is closely related to an increased risk of ... ...

    Abstract Sleep-disordered breathing has a relatively high prevalence, which varies from 3-7% in males and from 2-5% in females in the adult population. Studies published in the literature have shown that sleep apnea is closely related to an increased risk of developing various pathologies, among which arterial hypertension stands out. The prevalence of hypertension in patients suffering from obstructive sleep apnea (OSA) ranges from 35-80% and appears to be related to OSA severity. Approximately 40-50% of patients affected by hypertension are also affected by OSA and this association seems to be stronger in young and middle-aged adults (<50 years of age). The primary objective of this narrative review is to provide an update on what are the main contributing comorbidities to the development of a hypertensive state in patients suffering from OSA, an independent risk factor for diurnal hypertension, implicated as a risk factor for the first stroke, recurrent stroke, and post-stroke mortality. There are a lot of factors that contribute to developing a hypertensive state in OSA patients, some more decisive, others less. More evidence from longitudinal studies is needed on the impact of OSA on cardiovascular risk in females, on the causal link between OSA and arterial hypertension or metabolic diseases, like diabetes and glucose intolerance, and the effect of different kinds of OSA treatment.
    MeSH term(s) Adult ; Female ; Humans ; Male ; Middle Aged ; Comorbidity ; Diabetes Mellitus/epidemiology ; Hypertension/complications ; Hypertension/epidemiology ; Risk Factors ; Sleep Apnea, Obstructive/complications ; Sleep Apnea, Obstructive/epidemiology ; Young Adult
    Language English
    Publishing date 2023-11-10
    Publishing country Italy
    Document type Review ; Journal Article
    ZDB-ID 123586-2
    ISSN 1827-1669 ; 0026-4806
    ISSN (online) 1827-1669
    ISSN 0026-4806
    DOI 10.23736/S0026-4806.23.08466-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Feasibility of high-frequency percussions in people with severe acquired brain injury and tracheostomy: an observational study.

    Sciurello, Salvatore Andrea / Graziano, Francesca / Laganà, Maria Marcella / Compalati, Elena / Pappacoda, Gabriele / Gambazza, Simone / Navarro, Jorge / Cecconi, Pietro / Baglio, Francesca / Banfi, Paolo

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

    2024  

    Abstract: People with severe acquired brain injury (pwSABI) frequently experience pulmonary complications. Among these, atelectasis can occur as a result of pneumonia, thus increasing the chance of developing acute respiratory failure. Respiratory physiotherapy ... ...

    Abstract People with severe acquired brain injury (pwSABI) frequently experience pulmonary complications. Among these, atelectasis can occur as a result of pneumonia, thus increasing the chance of developing acute respiratory failure. Respiratory physiotherapy contribution to the management of atelectasis in pwSABI is yet poorly understood. We conducted a retrospective analysis on 15 non-cooperative pwSABI with tracheostomy and spontaneously breathing, hospitalized and treated with high-frequency percussion physiotherapy between September 2018 and February 2021 at the Neurological Rehabilitation Unit of the IRCCS "S.Maria Nascente - Fondazione Don Gnocchi", Milan. Our primary aim was to investigate the feasibility of such a physiotherapy intervention method. Then, we assessed changes in respiratory measures (arterial blood gas analysis and peripheral night-time oxygen saturation) and high-resolution computed tomography lung images, evaluated before and after the physiotherapy treatment. The radiological measures were a modified radiological atelectasis score (mRAS) assigned by two radiologists, and an opacity score automatically provided by the software CT Pneumonia Analysis® that identifies the regions of abnormal lung patterns. Treatment diaries showed that all treatments were completed, and no adverse events during treatment were registered. Among the 15 pwSABI analyzed, 8 were treated with IPV® and 7 with MetaNeb®. After a median of 14 (I-III quartile=12.5-14.5) days of treatment, we observed a statistical improvement in various arterial blood gas measures and peripheral night-time oxygen saturation measures. We also found radiological improvement or stability in more than 80% of pwSABI. In conclusion, our physiotherapy approach was feasible, and we observed respiratory parameters and radiological improvements. Using technology to assess abnormal tomographic patterns could be of interest to disentangle the short-term effects of respiratory physiotherapy on non-collaborating people.
    Language English
    Publishing date 2024-01-17
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1160940-0
    ISSN 1122-0643 ; 1120-0391
    ISSN 1122-0643 ; 1120-0391
    DOI 10.4081/monaldi.2024.2734
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The safety of carbamylated monomeric allergoids for sublingual immunotherapy. Data from a pharmacovigilance study.

    Compalati, Enrico / Incorvaia, Cristoforo / Urbano, Sara / Strada, Paola / Frati, Franco

    Immunotherapy

    2020  Volume 12, Issue 3, Page(s) 195–202

    Abstract: Aim: ...

    Abstract Aim:
    MeSH term(s) Allergens/chemistry ; Allergoids/administration & dosage ; Allergoids/adverse effects ; Allergoids/chemistry ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Humans ; Italy/epidemiology ; Pharmacovigilance ; Protein Carbamylation ; Safety ; Sublingual Immunotherapy/adverse effects ; Sublingual Immunotherapy/statistics & numerical data
    Chemical Substances Allergens ; Allergoids
    Language English
    Publishing date 2020-01-23
    Publishing country England
    Document type Journal Article
    ISSN 1750-7448
    ISSN (online) 1750-7448
    DOI 10.2217/imt-2019-0095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The role of allergoids in allergen immunotherapy: from injective to sublingual route.

    Compalati, E / Incorvaia, C / Cavaliere, C / Masieri, S / Gargiulo, A / Mistrello, G / Frati, F

    European annals of allergy and clinical immunology

    2020  Volume 52, Issue 5, Page(s) 195–204

    Abstract: Summary: ... ...

    Abstract Summary: Summary
    MeSH term(s) Administration, Sublingual ; Allergoids/immunology ; Animals ; Antigens, Dermatophagoides/immunology ; Antigens, Fungal/immunology ; Fungi/immunology ; Humans ; Hypersensitivity/immunology ; Immune Tolerance ; Injections ; Plants ; Pollen/immunology ; Pyroglyphidae
    Chemical Substances Allergoids ; Antigens, Dermatophagoides ; Antigens, Fungal
    Language English
    Publishing date 2020-09-08
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 2105540-3
    ISSN 1764-1489 ; 0397-9148
    ISSN 1764-1489 ; 0397-9148
    DOI 10.23822/EurAnnACI.1764-1489.142
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Efficacy of Nasal High-Flow Oxygen Therapy in Chronic Obstructive Pulmonary Disease Patients in Long-Term Oxygen and Nocturnal Non-Invasive Ventilation during Exercise Training.

    Volpi, Valeria / Volpato, Eleonora / Compalati, Elena / Lebret, Marius / Russo, Giuseppe / Sciurello, Salvatore / Pappacoda, Gabriele / Nicolini, Antonello / Banfi, Paolo

    Healthcare (Basel, Switzerland)

    2022  Volume 10, Issue 10

    Abstract: High-flow oxygen therapy (HFOT) improves gas exchange and dead space washout and reduces the level of work required for breathing. This study aimed to evaluate pulmonary rehabilitation (PR) combined with HFOT in COPD patients treated with nocturnal non- ... ...

    Abstract High-flow oxygen therapy (HFOT) improves gas exchange and dead space washout and reduces the level of work required for breathing. This study aimed to evaluate pulmonary rehabilitation (PR) combined with HFOT in COPD patients treated with nocturnal non-invasive ventilation (NIV) and long-term oxygen therapy (LTOT). In particular, we sought to discover whether the addition of HFOT during exercise training could improve patients’ performance, mainly with regard to their Six-Minute Walking Test (6MWT) outcomes, and reduce the exacerbation rates, periods of rehospitalization or need to resort to unscheduled visits. Thirty-one COPD subjects (13 female) who used nocturnal NIV were included in a randomized controlled trial and allocated to one of two groups: the experimental group (EG), with 15 subjects, subjected to PR with HFOT; and the control group (CG), with 16 subjects, subjected to PR without HFOT. The primary outcome of the study was the observation of changes in the 6MWT. The secondary outcome of the study was related to the rate of exacerbation and hospitalization. Data were collected at baseline and after one, two and three cycles of cycle-ergometer exercise training performed in 20 supervised sessions of 40 min thrice per week, with a washout period of 3 months between each rehabilitation cycle. Statistical significance was not found for the 6MWT distance (W = 0.974; p = 0.672) at the last follow-up, but statistical significance was found for the Borg scale in regard to dyspnea (W = 2.50; p < 0.001) and fatigue (W = 2.00; p < 0.001). HFOT may offer a positive option for dyspnea-affected COPD patients in the context of LTOT and nocturnal NIV.
    Language English
    Publishing date 2022-10-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2721009-1
    ISSN 2227-9032
    ISSN 2227-9032
    DOI 10.3390/healthcare10102001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top